{"entity":{"type":"insider","cik":"0001780060","url":"/insider/0001780060","json_url":"/insider/0001780060.json","name":"Touchon Pascal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":22,"first":"2020-05-20","last":"2024-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Touchon Pascal","source":"filing","n_filings":22,"first_seen":"2020-05-20","last_seen":"2024-08-20"}],"transactions":[{"id":2671649,"accession":"0000905148-24-002306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-24-002306","line_url":"/filing/0000905148-24-002306","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3038.0,"shares_display":"3,038","price_per_share":6.629090849242923,"price_display":"6.63","price_state":"stated","total_value":20139.178,"total_display":"20,139.18","total_whole":"20,139","shares_owned_after":70403.0,"shares_owned_after_display":"70,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":2380199,"accession":"0000905148-24-001561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-001561","line_url":"/filing/0000905148-24-001561#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81506.0,"shares_display":"81,506","price_per_share":0.617,"price_display":"0.62","price_state":"stated","total_value":50289.202,"total_display":"50,289.20","total_whole":"50,289","shares_owned_after":1829146.0,"shares_owned_after_display":"1,829,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2106771,"accession":"0000905148-24-000911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-000911","line_url":"/filing/0000905148-24-000911#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24844.0,"shares_display":"24,844","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":17887.68,"total_display":"17,887.68","total_whole":"17,888","shares_owned_after":1910652.0,"shares_owned_after_display":"1,910,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8310007,"accession":"0000905148-23-001513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-23-001513","line_url":"/filing/0000905148-23-001513#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20409.0,"shares_display":"20,409","price_per_share":0.389,"price_display":"0.39","price_state":"stated","total_value":7939.101,"total_display":"7,939.10","total_whole":"7,939","shares_owned_after":655496.0,"shares_owned_after_display":"655,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8182232,"accession":"0001140361-23-040562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-040562","line_url":"/filing/0001140361-23-040562","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30766.0,"shares_display":"30,766","price_per_share":1.6523033868556198,"price_display":"1.65","price_state":"stated","total_value":50834.766,"total_display":"50,834.77","total_whole":"50,835","shares_owned_after":685239.0,"shares_owned_after_display":"685,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider","n_lines":2},{"id":8103397,"accession":"0001140361-23-032216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-032216","line_url":"/filing/0001140361-23-032216#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14291.0,"shares_display":"14,291","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":23723.06,"total_display":"23,723.06","total_whole":"23,723","shares_owned_after":706671.0,"shares_owned_after_display":"706,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider"},{"id":8433946,"accession":"0001140361-23-025559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-025559","line_url":"/filing/0001140361-23-025559#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29766.0,"shares_display":"29,766","price_per_share":2.037,"price_display":"2.04","price_state":"stated","total_value":60633.342,"total_display":"60,633.34","total_whole":"60,633","shares_owned_after":720962.0,"shares_owned_after_display":"720,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":7944398,"accession":"0001567619-23-004540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-004540","line_url":"/filing/0001567619-23-004540#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15679.0,"shares_display":"15,679","price_per_share":3.627,"price_display":"3.63","price_state":"stated","total_value":56867.733,"total_display":"56,867.73","total_whole":"56,868","shares_owned_after":750728.0,"shares_owned_after_display":"750,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6809585,"accession":"0001140361-22-042380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-042380","line_url":"/filing/0001140361-22-042380#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15591.0,"shares_display":"15,591","price_per_share":4.49,"price_display":"4.49","price_state":"stated","total_value":70003.59,"total_display":"70,003.59","total_whole":"70,004","shares_owned_after":441696.0,"shares_owned_after_display":"441,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider"},{"id":6343283,"accession":"0001140361-22-030302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-030302","line_url":"/filing/0001140361-22-030302#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14806.0,"shares_display":"14,806","price_per_share":5.035,"price_display":"5.04","price_state":"stated","total_value":74548.21,"total_display":"74,548.21","total_whole":"74,548","shares_owned_after":457287.0,"shares_owned_after_display":"457,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":6376458,"accession":"0001567619-22-013481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-013481","line_url":"/filing/0001567619-22-013481#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14220.0,"shares_display":"14,220","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":102384.0,"total_display":"102,384.00","total_whole":"102,384","shares_owned_after":472093.0,"shares_owned_after_display":"472,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6112647,"accession":"0001140361-22-019978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-019978","line_url":"/filing/0001140361-22-019978#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13913.0,"shares_display":"13,913","price_per_share":5.316,"price_display":"5.32","price_state":"stated","total_value":73961.508,"total_display":"73,961.51","total_whole":"73,962","shares_owned_after":486313.0,"shares_owned_after_display":"486,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6112618,"accession":"0001140361-22-007764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-007764","line_url":"/filing/0001140361-22-007764#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8828.0,"shares_display":"8,828","price_per_share":9.856,"price_display":"9.86","price_state":"stated","total_value":87008.768,"total_display":"87,008.77","total_whole":"87,009","shares_owned_after":500226.0,"shares_owned_after_display":"500,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider"},{"id":5157204,"accession":"0001567619-21-020781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-020781","line_url":"/filing/0001567619-21-020781#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8402.0,"shares_display":"8,402","price_per_share":17.1169,"price_display":"17.12","price_state":"stated","total_value":143816.1938,"total_display":"143,816.19","total_whole":"143,816","shares_owned_after":328489.0,"shares_owned_after_display":"328,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":5377102,"accession":"0001567619-21-016151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-016151","line_url":"/filing/0001567619-21-016151#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8223.0,"shares_display":"8,223","price_per_share":12.532,"price_display":"12.53","price_state":"stated","total_value":103050.636,"total_display":"103,050.64","total_whole":"103,051","shares_owned_after":336891.0,"shares_owned_after_display":"336,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":4108406,"accession":"0001567619-21-012695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-012695","line_url":"/filing/0001567619-21-012695#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14194.0,"shares_display":"14,194","price_per_share":16.321,"price_display":"16.32","price_state":"stated","total_value":231660.274,"total_display":"231,660.27","total_whole":"231,660","shares_owned_after":345114.0,"shares_owned_after_display":"345,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-29","scope":"insider"},{"id":5198972,"accession":"0001209191-21-034425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034425","line_url":"/filing/0001209191-21-034425#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8313.0,"shares_display":"8,313","price_per_share":14.55,"price_display":"14.55","price_state":"stated","total_value":120954.15,"total_display":"120,954.15","total_whole":"120,954","shares_owned_after":359308.0,"shares_owned_after_display":"359,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"},{"id":5394804,"accession":"0001209191-21-017768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017768","line_url":"/filing/0001209191-21-017768#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4887.0,"shares_display":"4,887","price_per_share":16.74,"price_display":"16.74","price_state":"stated","total_value":81808.38,"total_display":"81,808.38","total_whole":"81,808","shares_owned_after":367621.0,"shares_owned_after_display":"367,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":2659153,"accession":"0001209191-20-059044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-059044","line_url":"/filing/0001209191-20-059044#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4716.0,"shares_display":"4,716","price_per_share":19.774,"price_display":"19.77","price_state":"stated","total_value":93254.184,"total_display":"93,254.18","total_whole":"93,254","shares_owned_after":255321.0,"shares_owned_after_display":"255,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-18","scope":"insider"},{"id":2546238,"accession":"0001209191-20-047821","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047821","line_url":"/filing/0001209191-20-047821#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4807.0,"shares_display":"4,807","price_per_share":12.09,"price_display":"12.09","price_state":"stated","total_value":58116.63,"total_display":"58,116.63","total_whole":"58,117","shares_owned_after":260037.0,"shares_owned_after_display":"260,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2881224,"accession":"0001209191-20-039077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-039077","line_url":"/filing/0001209191-20-039077#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12135.0,"shares_display":"12,135","price_per_share":12.92,"price_display":"12.92","price_state":"stated","total_value":156784.2,"total_display":"156,784.20","total_whole":"156,784","shares_owned_after":264844.0,"shares_owned_after_display":"264,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-26","scope":"insider"},{"id":2729980,"accession":"0001209191-20-031004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031004","line_url":"/filing/0001209191-20-031004#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001780060","owner_name":"Touchon Pascal","owner_display_name":"Touchon Pascal","owner_url":"/insider/0001780060","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3195.0,"shares_display":"3,195","price_per_share":11.22,"price_display":"11.22","price_state":"stated","total_value":35847.9,"total_display":"35,847.90","total_whole":"35,848","shares_owned_after":276979.0,"shares_owned_after_display":"276,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Director, Officer (President and CEO)","n_filings":22,"first_seen":"2020-05-20","last_seen":"2024-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780060","retrieved_at":"2026-08-23T09:31:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}